B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 15 840 KRW 8.42% Market Closed
Market Cap: 517.7B KRW

Binex Co Ltd's latest stock split occurred on May 2, 2011

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

The adjusted shares began trading on May 2, 2011. This was Binex Co Ltd's 3rd stock split, following the previous one in Aug 7, 2009.

Last Splits:
May 2, 2011
2-for-1
Aug 7, 2009
1250-for-1131
Sep 20, 2005
299-for-279
Pre-Split Price
N/A
Post-Split Price
5 650
Before
After
Last Splits:
May 2, 2011
2-for-1
Aug 7, 2009
1250-for-1131
Sep 20, 2005
299-for-279

Binex Co Ltd
Stock Splits History

Binex Co Ltd Stock Splits Timeline
May 2, 2011
May 2, 2011
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
5 650
Before
After
Aug 7, 2009
Aug 7, 2009
Split 1250-for-1131
x1.105216622458
Pre-Split Price
N/A
Post-Split Price
5 650
Before
After
Sep 20, 2005
Sep 20, 2005
Split 299-for-279
x1.0716845878136
Pre-Split Price
N/A
Post-Split Price
5 650
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
May 13, 2025
L
Lithos Energy Ltd
OTC:LITSF
1-for-10
/10
0.13 0.13 USD N/A
May 13, 2025
N
New Zealand Coastal Seafoods Ltd
OTC:NZSCF
1-for-10
/10
0.0003 0.003 USD N/A
May 13, 2025
Sienna Resources Inc
OTC:SNNAF
1-for-10
/10
0.155 0.155 USD N/A
May 13, 2025
S
Smec Co Ltd
KOSDAQ:099440
3958-for-3333
x1.1875187518752
2353.6471 2353.6471 KRW 2390 2390 KRW
May 12, 2025
C
Comprehensive Healthcare Systems Inc
XTSX:CHS
1-for-20
/20
0.01 0.2 CAD 0.2 0.2 CAD
Load More

Binex Co Ltd
Glance View

Market Cap
504.5B KRW
Industry
Pharmaceuticals

BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Busan, Busan. The company went IPO on 2001-08-07. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. The company also manufactures bio medicines and raw materials. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
11 583.7 KRW
Overvaluation 27%
Intrinsic Value
Price
B
Back to Top